EPZ-6438
EPZ-6438 is a potent and bio-available inhibitor of EZH2, the catalytic subunit of polycomb repressive complex 2 (PRC2) catalyzing the methylation of lysine 27 of histone H3 (H3K27), that inhibits the activity of human PRC2-containing wild-type EZH2 (Ki = 2.5 nM) .
Product Specifications
Background
EPZ-6438 competitively binds to the S-adenosylmethionine (SAM) binding site of EZH2 and also non-competitively binds to the binding sites of peptide or nucleosome substrate. EPZ-6438 selectively inhibits EZH2 with selectivity 35-fold greater than EZH1. Study results have suggested that EPZ-6438 exhibits dramatic and permanent anti-tumor activity in MRT models through synergistic effects of EPZ-6438-mediated EZH2 inhibition on several cancer pathways.
CAS Number
1403254-99-8
Purity
≥ 99% by HPLC
Solubility
Soluble in EtOH
Molecular Formula
C34H44N4O4
Shipping Conditions
Room Temperature (continental US) or Gel Packs
Storage Conditions
Store desiccated at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Calculated Molecular Weight
572.7 Da
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6335299-01 0.1 mL
PNLIP, CT (PNLIP, Pancreatic triacylglycerol lipase) (MaxLight 750)
Ask
View Details MBS6335299-02 5x 0.1 mL
PNLIP, CT (PNLIP, Pancreatic triacylglycerol lipase) (MaxLight 750)
Ask
View Details 